Randomized Trial of Glutathione With Anti-PD-1 and Chemotherapy in Advanced NSCLC

NCT06896422 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Non-Small Cell Lung Cancer
Chemotherapy
PD1 Antibody
Glutathione

Interventions

DRUG: Glutathione
DRUG: PD1 Inhibitor
DRUG: Chemotherapy

Sponsor

The First Affiliated Hospital of Zhengzhou University